Generic Avodart is used for treating symptoms of benign prostatic hyperplasia (BPH) or enlargement of the prostate gland. It also helps to reduce the risk of urinary blockage and the need for prostate surgery. More info »
I received both packets a few weeks ago and I am very pleased with the
service. Thank you for the extra 4 samples. When dealing with people so far
away, and through the internet, I sometimes wonder if I will even receive
anything for my money. I would not hesitate to use your services again or to
recommend you to friends. Again, Thank You.
Dutasteride May Slow Prostate Cancer Progression - OncLive
OncLiveDutasteride May Slow Prostate Cancer ProgressionOncLiveDutasteride, a 5α-reductase inhibitor approved for the treatment of benign prostatic hyperplasia, may postpone disease progression in men with low-risk prostate cancer who have opted for an active surveillance strategy, as well as the need to start .
Coronary Artery Disease May Boost Risk of Prostate Cancer - OncLive
OncLiveCoronary Artery Disease May Boost Risk of Prostate CancerOncLiveThe 4-year, phase III REDUCE study evaluated the 5α-reductase inhibitor dutasteride, 0.
5-alpha Reductase Inhibitors Help Prostate Cancer Patients on Active Surveillance - OncLive
OncLive5-alpha Reductase Inhibitors Help Prostate Cancer Patients on Active SurveillanceOncLiveHe added that these findings are supported by the double-blind, placebo-controlled Reduction by Dutasteride of Clinical Progression Events in Expectant Management of Prostate Cancer (REDEEM) trial, which was recently published in The Lancet.
New Therapy Is Essential for Men with Prostate Enlargement As Medications Have ... - Seattle Post Intelligencer
New Therapy Is Essential for Men with Prostate Enlargement As Medications Have .
Pricing pressures and Middle East unrest hit GSK profits - Pharma Times
Pricing pressures and Middle East unrest hit GSK profitsPharma TimesThe Avodart (dutasteride) franchise, for the treatment of benign prostatic hyperplasia, increased 11% to £186 million, while Lamictal (lamotrigine) for seizures and bipolar disorder, grew 29% to £148 million.